NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy
To learn if psilocybin can help to prevent or decrease the severity of chemotherapy-induced peripheral neuropathy (CIPN) in patients who are receiving chemotherapy for the treatment of breast, colorectal, and In this study, psilocybin is being compared to standard supportive care and to a placebo.
- Status
- planned
- Phase
- Phase 2
- Institution
- M.D. Anderson Cancer Center
- Principal investigator
- Moran Amit, MD
- Start date
- 2026-11-04
- End date
- 2031-01-31
- Registry ID
- NCT07227909
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.